The Significance of Lipids to Biofilm Formation in Candida albicans: An Emerging Perspective

被引:44
作者
Alim, Darakshan [1 ]
Sircaik, Shabnam [1 ]
Panwar, Sneh Lata [1 ]
机构
[1] Jawaharlal Nehru Univ, Yeast Mol Genet Lab, Sch Life Sci, New Delhi 110067, India
关键词
Candida albicans; biofilm; lipids; extracellular matrix; drug resistance; antifungal therapy; flippase; mixed-species biofilm; plasma membrane; transcription factors; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-MUTANS; GENE-EXPRESSION; TRANSBILAYER DISTRIBUTION; SACCHAROMYCES-CEREVISIAE; POLYMICROBIAL BIOFILMS; FLUCONAZOLE RESISTANCE; ANTIFUNGAL AGENTS; AZOLE RESISTANCE; IN-VITRO;
D O I
10.3390/jof4040140
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida albicans, the dimorphic opportunistic human fungal pathogen, is capable of forming highly drug-resistant biofilms in the human host. Formation of biofilm is a multistep and multiregulatory process involving various adaptive mechanisms. The ability of cells in a biofilm to alter membrane lipid composition is one such adaptation crucial for biofilm development in C. albicans. Lipids modulate mixed species biofilm formation in vivo and inherent antifungal resistance associated with these organized communities. Cells in C. albicans biofilms display phase-dependent changes in phospholipid classes and in levels of lipid raft formation. Systematic studies with genetically modified strains in which the membrane phospholipid composition can be manipulated are limited in C. albicans. In this review, we summarize the knowledge accumulated on the impact that alterations in phospholipids may have on the biofilm forming ability of C. albicans in the human host. This review may provide the requisite impetus to analyze lipids from a therapeutic standpoint in managing C. albicans biofilms.
引用
收藏
页数:18
相关论文
共 118 条
[11]   Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents [J].
Baillie, GS ;
Douglas, LJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (03) :397-403
[12]   Role of dimorphism in the development of Candida albicans biofilms [J].
Baillie, GS ;
Douglas, LJ .
JOURNAL OF MEDICAL MICROBIOLOGY, 1999, 48 (07) :671-679
[13]   UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence [J].
Banerjee, Mohua ;
Thompson, Delma S. ;
Lazzell, Anna ;
Carlisle, Patricia L. ;
Pierce, Christopher ;
Monteagudo, Carlos ;
Lopez-Ribot, Jose L. ;
Kadosh, David .
MOLECULAR BIOLOGY OF THE CELL, 2008, 19 (04) :1354-1365
[14]   The Nonsteroidal Antiinflammatory Drug Diclofenac Potentiates the In Vivo Activity of Caspofungin Against Candida albicans Biofilms [J].
Bink, Anna ;
Kucharikova, Sona ;
Neirinck, Bram ;
Vleugels, Jef ;
Van Dijck, Patrick ;
Cammue, Bruno P. A. ;
Thevissen, Karin .
JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (11) :1790-1797
[15]   THE INFLUENCE OF STREPTOCOCCUS-MUTANS ON ADHESION OF CANDIDA-ALBICANS TO ACRYLIC SURFACES INVITRO [J].
BRANTING, C ;
SUND, ML ;
LINDER, LE .
ARCHIVES OF ORAL BIOLOGY, 1989, 34 (05) :347-353
[16]   NRG1, a repressor of filamentous growth in C.albicans, is down-regulated during filament induction [J].
Braun, BR ;
Kadosh, D ;
Johnson, AD .
EMBO JOURNAL, 2001, 20 (17) :4753-4761
[17]   Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole [J].
Bruzual, Igor ;
Riggle, Perry ;
Hadley, Susan ;
Kumamoto, Carol A. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) :441-450
[18]  
Budtz-Jlrgensen E, 1996, Oral Dis, V2, P285
[19]  
Calderone RA, 2012, CANDIDA CANDIDIASIS
[20]   SYNERGISTIC EFFECT OF CANDIDA-ALBICANS AND STAPHYLOCOCCUS-AUREUS ON MOUSE MORTALITY [J].
CARLSON, E .
INFECTION AND IMMUNITY, 1982, 38 (03) :921-924